Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-05 00:46 | 2022-02-03 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $110.00 | 47,937 | $5,273,070 | 138,246 | -25.7% |
| 2021-11-03 23:44 | 2021-11-01 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $90.00 | 28,159 | $2,534,310 | 138,246 | -16.9% |
| 2021-10-28 23:34 | 2021-10-26 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $88.00 | 82,757 | $7,282,616 | 138,246 | -37.4% |
| 2021-09-08 02:57 | 2021-09-02 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | SALE | $87.00 | 2,625 | $228,375 | 140,201 | -1.8% |
| 2021-06-18 00:04 | 2021-06-15 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $86.00 | 67,552 | $5,809,472 | 142,826 | -32.1% |
| 2021-05-11 00:18 | 2021-05-07 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | SALE | $84.00 | 9,477 | $796,068 | 144,697 | -6.1% |
| 2021-01-13 01:41 | 2021-01-08 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $75.00 | 58,896 | $4,417,200 | 46,008 | -56.1% |
| 2019-11-07 00:22 | 2019-11-04 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $68.00 | 23,604 | $1,605,072 | 84,317 | -21.9% |
| 2018-11-17 00:19 | 2018-11-14 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | SALE | $82.00 | 14,229 | $1,166,778 | 70,494 | -16.8% |
| 2017-03-22 23:20 | 2017-03-21 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $78.73 | 23,849 | $1,877,632 | 70,460 | -25.3% |
| 2016-05-06 23:28 | 2016-05-05 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | SALE | $105.00 | 7,517 | $789,285 | 69,601 | -9.7% |
| 2016-03-12 00:08 | 2016-03-09 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP, Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | SALE | $100.00 | 6,755 | $675,500 | 69,601 | -8.8% |
| 2015-10-28 23:50 | 2015-10-27 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP, Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $105.00 | 23,603 | $2,478,315 | 61,841 | -27.6% |
| 2015-04-03 23:56 | 2015-04-01 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP, Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $102.48 | 33,384 | $3,421,336 | 61,841 | -35.1% |
| 2015-03-24 23:12 | 2015-03-23 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP, Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $104.94 | 33,274 | $3,491,774 | 55,086 | -37.7% |
| 2015-01-06 00:58 | 2015-01-02 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP, Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $95.71 | 50,240 | $4,808,516 | 41,247 | -54.9% |
| 2014-03-31 23:56 | 2014-03-28 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP, Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | SALE | $74.33 | 18,867 | $1,402,388 | 33,468 | -36.1% |
| 2013-11-19 00:19 | 2013-11-18 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP, Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $65.61 | 35,387 | $2,321,628 | 35,982 | -49.6% |
| 2013-04-16 23:35 | 2013-04-15 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP, Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $57.31 | 139,618 | $8,001,563 | 30,061 | -82.3% |
| 2013-03-20 23:20 | 2013-03-18 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP, Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $54.00 | 34,422 | $1,858,788 | 27,636 | -55.5% |
| 2012-04-04 22:58 | 2012-04-02 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP, Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $44.96 | 48,178 | $2,166,117 | 22,469 | -68.2% |
| 2012-02-22 23:49 | 2012-02-21 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP, Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $44.03 | 96,354 | $4,242,467 | 16,464 | -85.4% |
| 2008-11-18 23:53 | 2008-11-17 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | BUY | $28.26 | 10,616 | $300,008 | 10,616 | +100.0% |
| 2007-06-11 23:02 | 2007-06-08 | AET | N/A | Brennan Troyen A | Officer; SVP & Chief Medical Officer | Other | BUY | $52.14 | 1,930 | $100,627 | 1,930 | +100.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.